ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle

Mujalin Prasannarong, Fernando R. Santos, Erik J Henriksen

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The nonapeptide angiotensin II (ANG II) induces vasoconstriction via the ANG II type I receptor, while its splice product ANG-(1-7) elicits an antihypertensive effect via the Mas receptor. Although a critical role of ANG II in the etiology of skeletal muscle insulin resistance is well documented, the role of the ANG-(1-7)/Mas receptor axis in this context is poorly understood. Therefore, we determined whether ANG-(1-7) is effective in ameliorating the negative effects of ANG II on insulin-stimulated insulin signaling and glucose transport activity in isolated soleus muscle from normotensive lean Zucker rats. ANG II alone (500nM for 2h) decreased insulin-stimulated glucose transport activity by 45% (P<0.05). In the presence of 500-1000nM ANG-(1-7), insulin-stimulated glucose transport activity in muscle exposed to ANG II improved by ∼30% (P<0.05). Moreover, ANG-(1-7) treatment increased Akt Ser473 phosphorylation (47%, P<0.05) without an effect on glycogen synthase kinase-3β Ser9 phosphorylation. The dependence of ANG-(1-7) action on the Mas receptor was assessed using A779 peptide, a selective Mas receptor antagonist. The positive effects of ANG-(1-7) on insulin-stimulated glucose transport activity and Akt Ser473 phosphorylation in soleus muscle were completely prevented in presence of 1000nM A779. In conclusion, the present study demonstrates that ANG-(1-7), via a Mas receptor-dependent mechanism, can ameliorate the inhibitory effect of ANG II on glucose transport activity in mammalian skeletal muscle, associated with enhanced Akt phosphorylation. These results provide further evidence supporting the targeting of the renin-angiotensin system for interventions designed to reduce insulin resistance in skeletal muscle tissue.

Original languageEnglish (US)
Pages (from-to)369-373
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume426
Issue number3
DOIs
StatePublished - Sep 28 2012

Fingerprint

Phosphorylation
Angiotensin II
Muscle
Insulin Resistance
Rats
Skeletal Muscle
Insulin
7-Ala-angiotensin (1-7)
Glucose
Glycogen Synthase Kinase 3
Zucker Rats
Angiotensin I
Muscles
Angiotensin Receptors
Renin-Angiotensin System
Vasoconstriction
Angiotensins
Antihypertensive Agents
angiotensin I (1-7)
Renin

Keywords

  • A779 peptide
  • Glucose transport
  • Insulin signaling
  • Soleus muscle

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. / Prasannarong, Mujalin; Santos, Fernando R.; Henriksen, Erik J.

In: Biochemical and Biophysical Research Communications, Vol. 426, No. 3, 28.09.2012, p. 369-373.

Research output: Contribution to journalArticle

@article{c3f6afd668a9455d8f5727516bb36203,
title = "ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle",
abstract = "The nonapeptide angiotensin II (ANG II) induces vasoconstriction via the ANG II type I receptor, while its splice product ANG-(1-7) elicits an antihypertensive effect via the Mas receptor. Although a critical role of ANG II in the etiology of skeletal muscle insulin resistance is well documented, the role of the ANG-(1-7)/Mas receptor axis in this context is poorly understood. Therefore, we determined whether ANG-(1-7) is effective in ameliorating the negative effects of ANG II on insulin-stimulated insulin signaling and glucose transport activity in isolated soleus muscle from normotensive lean Zucker rats. ANG II alone (500nM for 2h) decreased insulin-stimulated glucose transport activity by 45{\%} (P<0.05). In the presence of 500-1000nM ANG-(1-7), insulin-stimulated glucose transport activity in muscle exposed to ANG II improved by ∼30{\%} (P<0.05). Moreover, ANG-(1-7) treatment increased Akt Ser473 phosphorylation (47{\%}, P<0.05) without an effect on glycogen synthase kinase-3β Ser9 phosphorylation. The dependence of ANG-(1-7) action on the Mas receptor was assessed using A779 peptide, a selective Mas receptor antagonist. The positive effects of ANG-(1-7) on insulin-stimulated glucose transport activity and Akt Ser473 phosphorylation in soleus muscle were completely prevented in presence of 1000nM A779. In conclusion, the present study demonstrates that ANG-(1-7), via a Mas receptor-dependent mechanism, can ameliorate the inhibitory effect of ANG II on glucose transport activity in mammalian skeletal muscle, associated with enhanced Akt phosphorylation. These results provide further evidence supporting the targeting of the renin-angiotensin system for interventions designed to reduce insulin resistance in skeletal muscle tissue.",
keywords = "A779 peptide, Glucose transport, Insulin signaling, Soleus muscle",
author = "Mujalin Prasannarong and Santos, {Fernando R.} and Henriksen, {Erik J}",
year = "2012",
month = "9",
day = "28",
doi = "10.1016/j.bbrc.2012.08.093",
language = "English (US)",
volume = "426",
pages = "369--373",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle

AU - Prasannarong, Mujalin

AU - Santos, Fernando R.

AU - Henriksen, Erik J

PY - 2012/9/28

Y1 - 2012/9/28

N2 - The nonapeptide angiotensin II (ANG II) induces vasoconstriction via the ANG II type I receptor, while its splice product ANG-(1-7) elicits an antihypertensive effect via the Mas receptor. Although a critical role of ANG II in the etiology of skeletal muscle insulin resistance is well documented, the role of the ANG-(1-7)/Mas receptor axis in this context is poorly understood. Therefore, we determined whether ANG-(1-7) is effective in ameliorating the negative effects of ANG II on insulin-stimulated insulin signaling and glucose transport activity in isolated soleus muscle from normotensive lean Zucker rats. ANG II alone (500nM for 2h) decreased insulin-stimulated glucose transport activity by 45% (P<0.05). In the presence of 500-1000nM ANG-(1-7), insulin-stimulated glucose transport activity in muscle exposed to ANG II improved by ∼30% (P<0.05). Moreover, ANG-(1-7) treatment increased Akt Ser473 phosphorylation (47%, P<0.05) without an effect on glycogen synthase kinase-3β Ser9 phosphorylation. The dependence of ANG-(1-7) action on the Mas receptor was assessed using A779 peptide, a selective Mas receptor antagonist. The positive effects of ANG-(1-7) on insulin-stimulated glucose transport activity and Akt Ser473 phosphorylation in soleus muscle were completely prevented in presence of 1000nM A779. In conclusion, the present study demonstrates that ANG-(1-7), via a Mas receptor-dependent mechanism, can ameliorate the inhibitory effect of ANG II on glucose transport activity in mammalian skeletal muscle, associated with enhanced Akt phosphorylation. These results provide further evidence supporting the targeting of the renin-angiotensin system for interventions designed to reduce insulin resistance in skeletal muscle tissue.

AB - The nonapeptide angiotensin II (ANG II) induces vasoconstriction via the ANG II type I receptor, while its splice product ANG-(1-7) elicits an antihypertensive effect via the Mas receptor. Although a critical role of ANG II in the etiology of skeletal muscle insulin resistance is well documented, the role of the ANG-(1-7)/Mas receptor axis in this context is poorly understood. Therefore, we determined whether ANG-(1-7) is effective in ameliorating the negative effects of ANG II on insulin-stimulated insulin signaling and glucose transport activity in isolated soleus muscle from normotensive lean Zucker rats. ANG II alone (500nM for 2h) decreased insulin-stimulated glucose transport activity by 45% (P<0.05). In the presence of 500-1000nM ANG-(1-7), insulin-stimulated glucose transport activity in muscle exposed to ANG II improved by ∼30% (P<0.05). Moreover, ANG-(1-7) treatment increased Akt Ser473 phosphorylation (47%, P<0.05) without an effect on glycogen synthase kinase-3β Ser9 phosphorylation. The dependence of ANG-(1-7) action on the Mas receptor was assessed using A779 peptide, a selective Mas receptor antagonist. The positive effects of ANG-(1-7) on insulin-stimulated glucose transport activity and Akt Ser473 phosphorylation in soleus muscle were completely prevented in presence of 1000nM A779. In conclusion, the present study demonstrates that ANG-(1-7), via a Mas receptor-dependent mechanism, can ameliorate the inhibitory effect of ANG II on glucose transport activity in mammalian skeletal muscle, associated with enhanced Akt phosphorylation. These results provide further evidence supporting the targeting of the renin-angiotensin system for interventions designed to reduce insulin resistance in skeletal muscle tissue.

KW - A779 peptide

KW - Glucose transport

KW - Insulin signaling

KW - Soleus muscle

UR - http://www.scopus.com/inward/record.url?scp=84866893212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866893212&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.08.093

DO - 10.1016/j.bbrc.2012.08.093

M3 - Article

C2 - 22960175

AN - SCOPUS:84866893212

VL - 426

SP - 369

EP - 373

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -